CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company
Inhibikase Therapeutics, Inc.
Sign in to watch- Ticker
- IKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 263407249
- Phone
- (302) 295-3800
- Business address
- 1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13D Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
Page 12 of 19 · 370 filings